Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals
{{output}}
Objectives: In clinical chimeric antigen receptor (CAR) T cell therapy, one of the strongest correlates of favorable patient responses is lower levels of differentiation in T cells from the peripheral blood mononuclear cell (PBMC... ...
